Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36


Disposition of Basal Insulin Peglispro Compared with 20-kDa Polyethylene Glycol in Rats Following a Single Intravenous or Subcutaneous Dose.

Knadler MP, Ellis BB, Brown-Augsburger PL, Murphy AT, Martin JA, Wroblewski VJ.

Drug Metab Dispos. 2015 Oct;43(10):1477-83. doi: 10.1124/dmd.115.064337. Epub 2015 Jul 14.


A Randomized Controlled Trial to Reduce Falls in People With Parkinson's Disease.

Morris ME, Menz HB, McGinley JL, Watts JJ, Huxham FE, Murphy AT, Danoudis ME, Iansek R.

Neurorehabil Neural Repair. 2015 Sep;29(8):777-85. doi: 10.1177/1545968314565511. Epub 2015 Jan 7.


Hepcidin as a predictive factor and therapeutic target in erythropoiesis-stimulating agent treatment for anemia of chronic disease in rats.

Theurl M, Nairz M, Schroll A, Sonnweber T, Asshoff M, Haschka D, Seifert M, Willenbacher W, Wilflingseder D, Posch W, Murphy AT, Witcher DR, Theurl I, Weiss G.

Haematologica. 2014 Sep;99(9):1516-24. doi: 10.3324/haematol.2013.099481. Epub 2014 Jun 3.


Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB.

Sonnweber T, Nachbaur D, Schroll A, Nairz M, Seifert M, Demetz E, Haschka D, Mitterstiller AM, Kleinsasser A, Burtscher M, Trübsbach S, Murphy AT, Wroblewski V, Witcher DR, Mleczko-Sanecka K, Vecchi C, Muckenthaler MU, Pietrangelo A, Theurl I, Weiss G.

Gut. 2014 Dec;63(12):1951-9. doi: 10.1136/gutjnl-2013-305317. Epub 2014 Mar 5.


Obstacle crossing in Parkinson's disease: mediolateral sway of the centre of mass during level-ground walking and obstacle crossing.

Galna B, Murphy AT, Morris ME.

Gait Posture. 2013 Sep;38(4):790-4. doi: 10.1016/j.gaitpost.2013.03.024. Epub 2013 May 4.


Determinants of health-related quality of life in people with Parkinson's disease: a path analysis.

Soh SE, McGinley JL, Watts JJ, Iansek R, Murphy AT, Menz HB, Huxham F, Morris ME.

Qual Life Res. 2013 Sep;22(7):1543-53. doi: 10.1007/s11136-012-0289-1. Epub 2012 Oct 16.


Health-related quality of life and strain in caregivers of Australians with Parkinson's disease: an observational study.

Kelly DH, McGinley JL, Huxham FE, Menz HB, Watts JJ, Iansek R, Murphy AT, Danoudis M, Adair B, Morris ME.

BMC Neurol. 2012 Jul 17;12:57. doi: 10.1186/1471-2377-12-57.


High-fat diet causes iron deficiency via hepcidin-independent reduction of duodenal iron absorption.

Sonnweber T, Ress C, Nairz M, Theurl I, Schroll A, Murphy AT, Wroblewski V, Witcher DR, Moser P, Ebenbichler CF, Kaser S, Weiss G.

J Nutr Biochem. 2012 Dec;23(12):1600-8. doi: 10.1016/j.jnutbio.2011.10.013. Epub 2012 Mar 23.


Feasibility, safety, and compliance in a randomized controlled trial of physical therapy for Parkinson's disease.

McGinley JL, Martin C, Huxham FE, Menz HB, Danoudis M, Murphy AT, Watts JJ, Iansek R, Morris ME.

Parkinsons Dis. 2012;2012:795294. doi: 10.1155/2012/795294. Epub 2011 Dec 10.


Falls and mobility in Parkinson's disease: protocol for a randomised controlled clinical trial.

Morris ME, Menz HB, McGinley JL, Huxham FE, Murphy AT, Iansek R, Danoudis M, Soh SE, Kelly D, Watts JJ.

BMC Neurol. 2011 Jul 31;11:93. doi: 10.1186/1471-2377-11-93.


Identification of a common variant in the TFR2 gene implicated in the physiological regulation of serum iron levels.

Pichler I, Minelli C, Sanna S, Tanaka T, Schwienbacher C, Naitza S, Porcu E, Pattaro C, Busonero F, Zanon A, Maschio A, Melville SA, Grazia Piras M, Longo DL, Guralnik J, Hernandez D, Bandinelli S, Aigner E, Murphy AT, Wroblewski V, Marroni F, Theurl I, Gnewuch C, Schadt E, Mitterer M, Schlessinger D, Ferrucci L, Witcher DR, Hicks AA, Weiss G, Uda M, Pramstaller PP.

Hum Mol Genet. 2011 Mar 15;20(6):1232-40. doi: 10.1093/hmg/ddq552. Epub 2010 Dec 28.


A dual-monoclonal sandwich ELISA specific for hepcidin-25.

Butterfield AM, Luan P, Witcher DR, Manetta J, Murphy AT, Wroblewski VJ, Konrad RJ.

Clin Chem. 2010 Nov;56(11):1725-32. doi: 10.1373/clinchem.2010.151522. Epub 2010 Sep 16.


Obstacle crossing in people with Parkinson's disease: foot clearance and spatiotemporal deficits.

Galna B, Murphy AT, Morris ME.

Hum Mov Sci. 2010 Oct;29(5):843-52. doi: 10.1016/j.humov.2009.09.006. Epub 2009 Dec 3.


Growth differentiation factor 15 in anaemia of chronic disease, iron deficiency anaemia and mixed type anaemia.

Theurl I, Finkenstedt A, Schroll A, Nairz M, Sonnweber T, Bellmann-Weiler R, Theurl M, Seifert M, Wroblewski VJ, Murphy AT, Witcher D, Zoller H, Weiss G.

Br J Haematol. 2010 Feb;148(3):449-55. doi: 10.1111/j.1365-2141.2009.07961.x. Epub 2009 Oct 15.


Obstacle crossing deficits in older adults: a systematic review.

Galna B, Peters A, Murphy AT, Morris ME.

Gait Posture. 2009 Oct;30(3):270-5. doi: 10.1016/j.gaitpost.2009.05.022. Epub 2009 Jul 21. Review.


Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications.

Theurl I, Aigner E, Theurl M, Nairz M, Seifert M, Schroll A, Sonnweber T, Eberwein L, Witcher DR, Murphy AT, Wroblewski VJ, Wurz E, Datz C, Weiss G.

Blood. 2009 May 21;113(21):5277-86. doi: 10.1182/blood-2008-12-195651. Epub 2009 Mar 17.


Quantifying the profile and progression of impairments, activity, participation, and quality of life in people with Parkinson disease: protocol for a prospective cohort study.

Morris ME, Watts JJ, Iansek R, Jolley D, Campbell D, Murphy AT, Martin CL.

BMC Geriatr. 2009 Jan 20;9:2. doi: 10.1186/1471-2318-9-2.


Regulation of iron metabolism through GDF15 and hepcidin in pyruvate kinase deficiency.

Finkenstedt A, Bianchi P, Theurl I, Vogel W, Witcher DR, Wroblewski VJ, Murphy AT, Zanella A, Zoller H.

Br J Haematol. 2009 Mar;144(5):789-93. doi: 10.1111/j.1365-2141.2008.07535.x. Epub 2008 Dec 20.


Cost effectiveness of preventing falls and improving mobility in people with Parkinson disease: protocol for an economic evaluation alongside a clinical trial.

Watts JJ, McGinley JL, Huxham F, Menz HB, Iansek R, Murphy AT, Waller ER, Morris ME.

BMC Geriatr. 2008 Sep 30;8:23. doi: 10.1186/1471-2318-8-23.


Behavioral, biochemical, and genetic analysis of iron metabolism in high-intensity blood donors.

Mast AE, Foster TM, Pinder HL, Beczkiewicz CA, Bellissimo DB, Murphy AT, Kovacevic S, Wroblewski VJ, Witcher DR.

Transfusion. 2008 Oct;48(10):2197-204. doi: 10.1111/j.1537-2995.2008.01823.x. Epub 2008 Jul 24.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk